Susquehanna International Group, LLP Night Hawk Biosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.77 - $1.62 $4,235 - $8,910	-5,500 Reduced 23.4%	18,000 $14,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $13,246 - $21,904	-7,400 Reduced 23.95%	23,500 $41,000
Q2 2022 Aug 15, 2022	SELL	$1.65 - $3.13 $23,925 - $45,385	-14,500 Reduced 31.94%	30,900 $79,000
Q1 2022 May 16, 2022	SELL	$2.1 - $3.54 $1,890 - $3,186	-900 Reduced 1.94%	45,400 $139,000
Q4 2021 Feb 14, 2022	BUY	$3.04 - $6.01 $42,864 - $84,741	14,100 Added 43.79%	46,300 $141,000
Q3 2021 Nov 15, 2021	SELL	$5.9 - $7.44 $887,360 - $1.12 Million	-150,400 Reduced 82.37%	32,200 $192,000
Q2 2021 Aug 11, 2021	BUY	$5.78 - $9.6 $749,666 - $1.25 Million	129,700 Added 245.18%	182,600 $1.23 Million
Q1 2021 May 17, 2021	BUY	$5.67 - $12.54 $299,943 - $663,366	52,900 New	52,900 $385,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.